(Total Views: 692)
Posted On: 02/07/2023 4:34:46 PM
Post# of 154977
Looks like you may have uncovered something interesting, Ritz.
The mild-to-moderate covid results had QC issues flagged when they were submitted for posting on the clinical trials site late last year, which were rectified, but now the recently submitted NASH results have been flagged with the same type of issues, and I expect those to be rectified soon. Maybe the errors in the submissions that needed clean-up have something to do with Recknor not being around anymore. Maybe that's too much speculation though.
My guess has been that the plan is to be more transparent than the past regime, thus recent appearance of the CD02, M2M and NASH trial results on clinicaltrials.gov, but I guess it those appearances could have something to do with the hold. One way or another, just a little more evidence that things are in the process of getting sorted correctly.
The mild-to-moderate covid results had QC issues flagged when they were submitted for posting on the clinical trials site late last year, which were rectified, but now the recently submitted NASH results have been flagged with the same type of issues, and I expect those to be rectified soon. Maybe the errors in the submissions that needed clean-up have something to do with Recknor not being around anymore. Maybe that's too much speculation though.
My guess has been that the plan is to be more transparent than the past regime, thus recent appearance of the CD02, M2M and NASH trial results on clinicaltrials.gov, but I guess it those appearances could have something to do with the hold. One way or another, just a little more evidence that things are in the process of getting sorted correctly.
(5)
(0)
